Herold Advisors, Inc. Nektar Therapeutics Transaction History

Herold Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$3.17 - $6.17 $32,334 - $62,934	-10,200 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$4.16 - $13.72 $34,528 - $113,876	-8,300 Reduced 44.86%	10,200 $54,000
Q4 2021 Jan 20, 2022	BUY	$10.83 - $18.41 $33,573 - $57,071	3,100 Added 20.13%	18,500 $249,000
Q3 2021 Nov 03, 2021	BUY	$13.07 - $18.84 $201,278 - $290,136	15,400 New	15,400 $276,000

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Herold Advisors, Inc. with notifications on news.